Legal & General Group Plc Lowers Holdings in Ventas, Inc. $VTR

Legal & General Group Plc lessened its stake in Ventas, Inc. (NYSE:VTR) by 0.2% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,344,206 shares of the real estate investment trust’s stock after selling 8,393 shares during the quarter. Legal & General Group Plc’s holdings in Ventas were worth $374,041,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently bought and sold shares of VTR. Cloud Capital Management LLC bought a new stake in Ventas during the 3rd quarter valued at about $25,000. True Wealth Design LLC lifted its stake in shares of Ventas by 1,557.7% in the third quarter. True Wealth Design LLC now owns 431 shares of the real estate investment trust’s stock worth $30,000 after buying an additional 405 shares in the last quarter. Wilmington Savings Fund Society FSB lifted its stake in shares of Ventas by 65.5% in the third quarter. Wilmington Savings Fund Society FSB now owns 455 shares of the real estate investment trust’s stock worth $32,000 after buying an additional 180 shares in the last quarter. ORG Partners LLC grew its holdings in shares of Ventas by 76.1% during the third quarter. ORG Partners LLC now owns 456 shares of the real estate investment trust’s stock valued at $32,000 after buying an additional 197 shares during the last quarter. Finally, Elevation Point Wealth Partners LLC bought a new stake in shares of Ventas during the second quarter valued at approximately $35,000. Institutional investors own 94.18% of the company’s stock.

Ventas Trading Down 0.3%

Shares of VTR stock opened at $85.81 on Thursday. The company has a current ratio of 0.67, a quick ratio of 0.67 and a debt-to-equity ratio of 1.03. Ventas, Inc. has a 12-month low of $60.15 and a 12-month high of $87.87. The stock has a market capitalization of $40.76 billion, a P/E ratio of 158.91, a P/E/G ratio of 2.10 and a beta of 0.73. The firm’s 50 day moving average is $81.10 and its 200 day moving average is $76.12.

Ventas (NYSE:VTR) last announced its earnings results on Thursday, February 5th. The real estate investment trust reported $0.15 earnings per share for the quarter, missing analysts’ consensus estimates of $0.89 by ($0.74). The company had revenue of ($1,229.71) million for the quarter, compared to analysts’ expectations of $1.53 billion. Ventas had a net margin of 4.31% and a return on equity of 2.09%. Ventas’s quarterly revenue was up 21.7% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.81 earnings per share. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. Research analysts expect that Ventas, Inc. will post 3.4 earnings per share for the current year.

Ventas Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, April 16th. Investors of record on Tuesday, March 31st will be given a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a yield of 2.4%. This is a boost from Ventas’s previous quarterly dividend of $0.48. The ex-dividend date is Tuesday, March 31st. Ventas’s dividend payout ratio (DPR) is currently 355.56%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on the stock. Scotiabank boosted their price objective on shares of Ventas from $80.00 to $93.00 and gave the stock a “sector perform” rating in a report on Monday, March 2nd. Cantor Fitzgerald reissued an “overweight” rating and issued a $93.00 target price on shares of Ventas in a report on Monday, February 9th. Royal Bank Of Canada boosted their price target on Ventas from $83.00 to $91.00 and gave the stock an “outperform” rating in a research note on Tuesday, February 10th. The Goldman Sachs Group reaffirmed a “buy” rating and set a $100.00 price target on shares of Ventas in a report on Monday, February 9th. Finally, Citigroup increased their price objective on Ventas from $88.00 to $96.00 and gave the company a “buy” rating in a research report on Wednesday, February 11th. Thirteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $89.00.

Insider Buying and Selling at Ventas

In other Ventas news, EVP Carey S. Roberts sold 35,532 shares of the stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $85.00, for a total value of $3,020,220.00. Following the transaction, the executive vice president owned 72,755 shares of the company’s stock, valued at approximately $6,184,175. This represents a 32.81% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Debra A. Cafaro sold 10,322 shares of the firm’s stock in a transaction dated Monday, February 2nd. The stock was sold at an average price of $77.66, for a total value of $801,606.52. Following the completion of the transaction, the chief executive officer directly owned 1,114,034 shares in the company, valued at $86,515,880.44. The trade was a 0.92% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders have sold 86,106 shares of company stock valued at $6,931,397. 0.80% of the stock is owned by company insiders.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.